Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22063048 | 0.90 | TP53 (0.41) | TP53MAPTRXFP1HSD17B10KDM4E | |
| SCHEMBL22063339 | 0.89 | KDM4E (0.44) | TP53MAPTRXFP1HSD17B10KDM4E | |
| SCHEMBL22062533 | 0.87 | ALDH1A1 (0.44) | TP53MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL22062532 | 0.86 | HPGD (0.48) | TP53MAPTTHRBHSD17B10KDM4E | |
| SCHEMBL22087373 | 0.84 | MAPT (0.41) | TP53MAPTRXFP1THRBHSD17B10 | |
| SCHEMBL22063202 | 0.84 | KDM4E (0.46) | TP53MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL22063050 | 0.84 | ALDH1A1 (0.46) | TP53MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL22063055 | 0.84 | SMN1; SMN2 (0.43) | TP53MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL22062710 | 0.83 | CASR (0.37) | TP53MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL22062528 | 0.82 | KDM4E (0.39) | TP53MAPTHSD17B10KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | TP53 4214/4885MAPT 2667/4885RXFP1 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.